Skip to content

indium In 111 monoclonal antibody MN-14

RADIATION6 trials

Sponsors

Garden State Cancer Center at the Center for Molecular Medicine and Immunology

Conditions

Colorectal CancerHead and Neck CancerLeukemiaLung CancerLymphomaOvarian CancerPancreatic Cancer

Phase 1

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
NCT00006347
Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyLung Cancer
Start: 2000-08-31Updated: 2009-03-03
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer
NCT00006458
Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyLung Cancer
Start: 2000-08-31Updated: 2009-03-03
Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer
CompletedNCT00004048
Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyHead and Neck Cancer
Start: 1998-09-30End: 2002-05-31Target: 30Updated: 2011-06-22
Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia
CompletedNCT00004107
Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyLeukemia, Lymphoma
Start: 1998-02-28Target: 18Updated: 2011-06-22
Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer
CompletedNCT00004087
Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyColorectal Cancer, Pancreatic Cancer
Start: 1997-03-31Target: 15Updated: 2011-06-22
Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer
CompletedNCT00004177
Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOvarian Cancer
Start: 1999-08-31Target: 15Updated: 2011-06-22